Cargando…
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study
We aimed to characterize non-oncologic chronic drug therapy of bladder cancer (BC) patients and evaluate a possible impact on recurrence-free (RFS) and cancer-specific survival (CSS). Patients with a first diagnosis (FD) of BC or radical cystectomy (RC) were included in a prospective, monocentric, o...
Autores principales: | Strobach, Dorothea, Haimerl, Lisa, Mannell, Hanna, Stief, Christian G., Karl, Alexander, Grimm, Tobias, Buchner, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648271/ https://www.ncbi.nlm.nih.gov/pubmed/37959213 http://dx.doi.org/10.3390/jcm12216749 |
Ejemplares similares
-
Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer
por: Haimerl, Lisa, et al.
Publicado: (2021) -
Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020) -
Hepatic Impairment as a Risk Factor for Drug Safety: Suitability and Comparison of Four Liver Scores as Screening Tools
por: Golla, Kathrin, et al.
Publicado: (2023) -
Prognostic features for quality of life after radical cystectomy and orthotopic neobladder
por: Kretschmer, Alexander, et al.
Publicado: (2016) -
Prognostic impact of perioperative blood transfusions on oncological outcomes of patients with bladder cancer undergoing radical cystectomy: A systematic review
por: Volz, Yannic, et al.
Publicado: (2020)